Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylmalonyl-coenzyme A (methylmalonyl-CoA) is a thioester compound formed by the linkage of coenzyme A to methylmalonic acid. It serves as a crucial metabolic intermediate, particularly in the conversion of certain amino acids and odd-chain fatty acids into succinyl-CoA, which then enters the tricarboxylic acid (TCA) cycle. It is also involved in polyketide biosynthesis in bacteria and plants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylmalonyl-coenzyme A (None).